New elongase gene and production of.delta. 9-polyunsaturated fatty acids
CA 2442010 C · Owner: Lerchl, Jens · Inventors: Lerchl, Jens; Napier, Johnathan A.; Lazarus, Colin M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a new elongase gene having the sequence SEQ ID NO: 1 or its derivatives, to a gene construct comprising this sequence or its derivatives and to its use. The inventive nucleic acid sequence encodes a polypeptide which elongates .alpha.-linolenic acid (C18:3 d9 12, 15) by at , least two carbon atoms whereas .gamma.-linolenic acid (C 18:3 d6 9, 12) is , not elongated. The invention additionally relates to vectors or organisms comprising an elongase gene having the sequence SEQ ID NO: 1 or its derivatives. The invention further relates to a process for the production of polyunsaturated fatty acids (=PUFAs) with an organism which comprises the elongase gene and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 26, 2002 and granted July 30, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 26, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 26, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.